Format

Send to

Choose Destination
Am J Med Sci. 2016 Apr;351(4):380-6. doi: 10.1016/j.amjms.2016.01.011.

Diabetes and Stroke: Epidemiology, Pathophysiology, Pharmaceuticals and Outcomes.

Author information

1
Department of Neurology, Affiliated Hospital of Hainan Medical College, Haikou, Hainan, China; Department of Neurology, MUSC Stroke Center, Medical University of South Carolina, Charleston, South Carolina.
2
Department of Neurology, MUSC Stroke Center, Medical University of South Carolina, Charleston, South Carolina.
3
Department of Neurology, MUSC Stroke Center, Medical University of South Carolina, Charleston, South Carolina. Electronic address: feng@musc.edu.

Abstract

There has been a significant increase in obesity rates worldwide with the corresponding surge in diabetes. Diabetes causes various microvascular and macrovascular changes often culminating in major clinical complications, 1 of which, is stroke. Although gains have been made over the last 2 decades in reducing the burden of stroke, the recent rise in rates of diabetes threatens to reverse these advances. Of the several mechanistic stroke subtypes, individuals with diabetes are especially susceptible to the consequences of cerebral small vessel diseases. Hyperglycemia confers greater risk of stroke occurrence. This increased risk is often seen in individuals with diabetes and is associated with poorer clinical outcomes (including higher mortality), especially following ischemic stroke. Improving stroke outcomes in individuals with diabetes requires prompt and persistent implementation of evidence-based medical therapies as well as adoption of beneficial lifestyle practices.

KEYWORDS:

Diabetes; Hyperglycemia; Outcomes; Stroke; Stroke prevention

PMID:
27079344
PMCID:
PMC5298897
DOI:
10.1016/j.amjms.2016.01.011
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center